Second Sight Medical Products, Inc.
USPTO PatentsView assignee record - 135 granted patents across 29 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Second ranks #2,851 of 49,997 tracked US assignees by granted-patent volume, with 135 patents across 29 technology areas.
- #2,851
- of 49,997 US assignees by volume
- Top 24%
- by Innovation Score (44.9/100)
- 12.2
- avg claims per patent
- -82%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R2851 · US Corporation #2,851 · 135 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 135 grants
- TOP-DECILE #2,851/49,997
- PHOTO-FINISH RH US
- CPC-FOCUS A61N · 29 areas
- INNOV-PAR 44.9/100
- CLAIMS-RICH 12.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -82% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: RH US, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Second’s 44.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Second
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Chegg · near
Chegg · near
45 score
- Empresa Brasileira… · near
Empresa Brasileira… · near
45 score
- OneEvent · near
OneEvent · near
45 score
- Second Sight… · this assignee
Second Sight… · this assignee
45 score
- TE Connectivity… · near
TE Connectivity… · near
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Second's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Second?
Each dot is one of Second’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Second’s own 12.2 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Second's grants concentrate
Second Sight Medical Products, Inc. is a focused PatentsView assignee: 29 CPC subclasses with 91.9% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (30 grants) versus a trough of 1 in 2024. By volume, Second sits between RH US, LLC and Bruker Nano, Inc..
Second's three-year grant acceleration
From 2019–2021 to 2022–2024, Second Sight Medical Products, Inc. moved from 25 to 6 grants (0.24x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,051. See the growth leaderboard.
Who files at Second's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- RH US
RH US, LLC
135 patents
- Sanechips Technol…
Sanechips Technology Co., Ltd.
135 patents
- Spine Wave
Spine Wave, Inc.
135 patents
- Suntory Flowers
Suntory Flowers Limited
135 patents
- Tamura
Tamura Corporation
135 patents
- Toagosei
Toagosei Co., Ltd.
135 patents
- Warner Bros Enter…
Warner Bros. Entertainment Inc.
135 patents
- Second Sight Medi… ◀
Second Sight Medical Products, Inc.
135 patents
- Bruker Nano
Bruker Nano, Inc.
134 patents
What this shows Second holds 135 patents at rank #2,853, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Second
By rank, the assignees closest to #2,853 in granted patent volume.
- RH US, LLC #2,849 · 135 patents
- Sanechips Technology Co., Ltd. #2,850 · 135 patents
- Spine Wave, Inc. #2,851 · 135 patents
- Suntory Flowers Limited #2,852 · 135 patents
- Tamura Corporation #2,854 · 135 patents
- Toagosei Co., Ltd. #2,855 · 135 patents
- Warner Bros. Entertainment Inc. #2,856 · 135 patents
- Bruker Nano, Inc. #2,857 · 134 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in Second's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Second, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Second ranks #28 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
Similar claim depth
Nearest assignees by average claims per patent (12.2 here).
Second's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 30 | 22.2% |
| 2016 | 23 | 17.0% |
| 2017 | 24 | 17.8% |
| 2018 | 27 | 20.0% |
| 2019 | 10 | 7.4% |
| 2020 | 9 | 6.7% |
| 2021 | 6 | 4.4% |
| 2022 | 5 | 3.7% |
| 2024 | 1 | 0.7% |
Which technologies does Second Sight Medical Products, Inc. patent most?
Top 15 of 29 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Second Sight Medical Products, Inc.'s patent record in context - here's where to go next.
- Second Sight Medical Products, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 91.9% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #2,851 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Second Sight Medical Products, Inc. against RH US, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.